Polyunsaturated fatty acids (PUFA) regulate various
biological functions and are involved in a variety of diseases.
Eicosapentaenoic acid (20:5, EPA), one of the omega-3 PUFA, has been reported a number of actions including suppression of platelet aggregability and decrease in serum
lipids and is well known to be useful in preventing the atherosclerotic diseases. In this paper, we demonstrated that highly purified
ethyl eicosapentaenoate (EPA-E) prevents
cholesterol (CH)
gallstone formation in hamster model. Repeated administration of EPA-E to animals fed a lithogenic diet for 6 weeks decreased the incidences of both CH crystal and CH
gallstone formations in gallbladder bile. Contrary,
bezafibrate, one of
fibric acid derivative which were reported to increase CH saturation index (CSI) in bile, significantly increased the incidences of CH crystal and
gallstone formations. EPA-E did not affect the CSI, but markedly increased biliary
phospholipid concentration. In the same model,
ethyl palmitate (16:0),
ethyl oleate (18:1), ethyl linolate (18:2, omega-6) and
ethyl arachidonate (20:4, omega-6) had no effects both on biliary
lipids composition and CH
gallstone formation. These result suggest the benefit of EPA-E in the prevention of CH
gallstone.